É. Lagrange

828 total citations
49 papers, 422 citations indexed

About

É. Lagrange is a scholar working on Neurology, Molecular Biology and Pharmacology. According to data from OpenAlex, É. Lagrange has authored 49 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Neurology, 12 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in É. Lagrange's work include Amyotrophic Lateral Sclerosis Research (7 papers), Peripheral Neuropathies and Disorders (5 papers) and Prion Diseases and Protein Misfolding (4 papers). É. Lagrange is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (7 papers), Peripheral Neuropathies and Disorders (5 papers) and Prion Diseases and Protein Misfolding (4 papers). É. Lagrange collaborates with scholars based in France, United States and South Africa. É. Lagrange's co-authors include Jean‐Paul Vernoux, Peter S. Spencer, B. Jacquetin, William Camu, B. Fatton, Laurence Bouillet, V. Letouzey, P. Marès, Renaud de Tayrac and Michel Cosson and has published in prestigious journals such as Nature, Acta Neuropathologica and Analytical and Bioanalytical Chemistry.

In The Last Decade

É. Lagrange

43 papers receiving 402 citations

Peers

Countries citing papers authored by É. Lagrange

Since Specialization

Citations

This map shows the geographic impact of É. Lagrange's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by É. Lagrange with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites É. Lagrange more than expected).

Fields of papers citing papers by É. Lagrange

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by É. Lagrange. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by É. Lagrange. The network helps show where É. Lagrange may publish in the future.

Co-authorship network of co-authors of É. Lagrange

This figure shows the co-authorship network connecting the top 25 collaborators of É. Lagrange. A scholar is included among the top collaborators of É. Lagrange based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with É. Lagrange. É. Lagrange is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Use of assistive technology to assess distal motor function in subjects with neuromuscular disease 2025 ·PLOS Digital Health ·(unknown), Sylvain Roche, (unknown), Capucine de Lattre, (unknown), (unknown), É. Lagrange, (unknown), (unknown), (unknown), V. Gautheron, Léonard Féasson, Pascal Rippert, Carole Vuillerot	0
2	Cramp–Fasciculation Syndrome Associated with Natural and Added Chemicals in Popular Food Items 2024 ·Foods ·É. Lagrange, Jean‐Paul Vernoux, (unknown), William Camu, Peter S. Spencer	0
3	Corrected speciation and gyromitrin content of false morels linked to ALS patients with mostly slow-acetylator phenotypes 2024 ·eNeurologicalSci ·É. Lagrange, Marie‐Anne Loriot, (unknown), (unknown), (unknown), Claire Guissart, Timothy Y. James, Jean Paul Vernoux, William Camu, Ashootosh Tripathi, Peter S. Spencer	4
4	Clinical features and maternal and fetal outcomes in women with Guillain-Barré syndrome in pregnancy 2023 ·Journal of Neurology ·(unknown), Renê Faustino Gabriel, Cécile Cauquil, David Adams, (unknown), Thierry Maisonobe, David Osman, Matthieu Schmidt, Jean‐Baptiste Chanson, Kévin Bigaut, Guilhem Solé, Céline Tard, Guillaume Nicolas, Yann Péréon, Karine Auré, É. Lagrange, (unknown), Marc‐Antoine Labeyrie, Andoni Echaniz‐Laguna	1
5	Early-onset, conjugal, twin-discordant, and clusters of sporadic ALS: Pathway to discovery of etiology via lifetime exposome research 2023 ·Frontiers in Neuroscience ·(unknown), Valerie S. Palmer, Glen E. Kisby, É. Lagrange, B. Zane Horowitz, (unknown), J. Reis, Jean‐Paul Vernoux, Cédric Raoul, William Camu	7
6	An amyotrophic lateral sclerosis hot spot in the French Alps associated with genotoxic fungi 2021 ·Journal of the Neurological Sciences ·É. Lagrange, Jean‐Paul Vernoux, J. Reis, Valerie S. Palmer, William Camu, Peter S. Spencer	20
7	Warning on False or True Morels and Button Mushrooms with Potential Toxicity Linked to Hydrazinic Toxins: An Update 2020 ·Toxins ·É. Lagrange, Jean‐Paul Vernoux	14
8	Health risk assessment related to pinnatoxins in French shellfish 2020 ·Toxicon ·Nathalie Arnich, Éric Abadie, Nicolas Delcourt, Valérie Fessard, Jean-Marc Frémy, Vincent Hort, É. Lagrange, Thomas Maignien, Jordi Molgó, (unknown), Jean‐Paul Vernoux, César Mattei	29
9	Clinical Phenotype and Inheritance in Patients With C9ORF72 Hexanucleotide Repeat Expansion: Results From a Large French Cohort 2020 ·Frontiers in Neuroscience ·Florence Esselin, Kévin Mouzat, Anne Polge, Raúl Juntas‐Morales, Nicolas Pageot, Elisa De La Cruz, E Bernard, É. Lagrange, Véronique Danel, (unknown), (unknown), Erika Nogué, Marie‐Christine Picot, Serge Lumbroso, William Camu	9
10	Pinnatoxins’ Deleterious Effects on Cholinergic Networks: From Experimental Models to Human Health 2019 ·Marine Drugs ·Nicolas Delcourt, É. Lagrange, Éric Abadie, Valérie Fessard, Jean-Marc Frémy, Jean‐Paul Vernoux, (unknown), Thomas Maignien, Nathalie Arnich, Jordi Molgó, César Mattei	15
11	A Phase 3 Multicenter, Prospective, Open-Label Efficacy and Safety Study of Immune Globulin (Human) 10% Caprylate/Chromatography Purified in Patients with Myasthenia Gravis Exacerbations 2019 ·European Neurology ·Guntis Karelis, Rodica Bălașa, Jan De Bleecker, (unknown), Andrés Villa, Philip Van Damme, É. Lagrange, Jeannine M. Heckmann, Michael Nicolle, (unknown), Vera Bril, Elsa Mondou, (unknown), Junliang Chen, (unknown), (unknown), (unknown), (unknown)	21
12	Trouble neurologique et hépatite E : revue de la littérature 2018 ·La Revue de Médecine Interne ·(unknown), É. Lagrange, Laurence Bouillet	5
13	Development of an analytical procedure for quantifying the underivatized neurotoxin β-N-methylamino-l-alanine in brain tissues 2014 ·Analytical and Bioanalytical Chemistry ·(unknown), Audrey Combès, (unknown), Jérôme Vial, É. Lagrange, Valérie Pichon	17
14	Antibodies to clustered acetylcholine receptor: expanding the phenotype 2013 ·European Journal of Neurology ·Perrine Devic, P. Petiot, Thomas Simonet, T. Stojkovic, Émilien Delmont, J. Franques, Armelle Magot, Christophe Vial, É. Lagrange, Anne-Sophie Nicot, Valérie Risson, B. Eymard, Laurent Schaeffer	47
15	Hallucinations treated with rivastigmine in Creutzfeldt–Jakob disease 2011 ·Fundamental and Clinical Pharmacology ·Claire Chapuis, Olivier Casez, É. Lagrange, Pierrick Bedouch, (unknown)	2
16	Acute bilateral mydriasis associated with anti-GQ1b antibody 2010 ·Journal of Clinical Neuroscience ·Vanessa Fleury, (unknown), É. Lagrange, Gérard Besson, Christiane Caudie	10
17	Comment je traite… un endométriome par cœlioscopie ? 2010 ·Gynécologie Obstétrique & Fertilité ·Nicolas Bourdel, É. Lagrange, (unknown), К. Jardon, B. Rabischong, Jean Luc Pouly, G. Mage, Michel Canis	1
18	Un syndrome de Miller-Fisher associé à une IgG monoclonale lambda à activité anti-ganglioside GQ1b 2010 ·Annales de biologie clinique ·Christiane Caudie, É. Lagrange	1
19	Validation linguistique en français de la version courte du questionnaire sur la sexualité (PISQ-12) chez les patientes présentant un prolapsus génital et/ou une incontinence urinaire 2009 ·Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément ·B. Fatton, V. Letouzey, É. Lagrange, P. Marès, B. Jacquetin, Renaud de Tayrac	36
20	Experimental Infection of Mice by Fasciola hepática. 1961 ·É. Lagrange, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact